Skip to main content
editorial
. 2018 Nov 28;174(1):1–13. doi: 10.1007/s10549-018-5066-6

Fig. 3.

Fig. 3

Disease-free survival for patients who received NACT according to the administration of platinum agents. Kaplan–Meier curves show the disease-free survival for patients stratified according to the administration of platinum-based NACT. The analysis was confined to 24-month follow-up period because the follow-up time for patients who received a platinum agent was short. A new event was observed in two of 31 patients who received a platinum and in 12 of 60 patients who received standard anthracycline–taxane-based NACT (log-rank test, p value = 0.262)